The Leukemia Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center treats children and teens with all forms of leukemia, a cancer of the blood and bone marrow. If your child has relapsed leukemia or leukemia that isn't responding to treatment, we offer secondary treatment options including stem cell transplantation.
Leukemia, a cancer of the blood and bone marrow, is the most common type of cancer in children. The Leukemia Program at Dana-Farber/Boston Children's treats children with all forms of leukemia. If your child has relapsed leukemia or leukemia that isn't responding to treatment, we offer secondary treatment options including stem cell transplantation.
Clinicians in the Leukemia Program have expertise in treating all forms of leukemia, including:
The Leukemia Program at Dana-Farber/Boston Children's offers comprehensive diagnosis, treatment, consultation services, and long-term follow-up care for children and adolescents with hematologic malignancies. Members of our physician team have specific expertise in pediatric leukemias and are recognized as national leaders in the field.
Our areas of specialization include:
Treatment protocols used at Boston Children's Hospital and Dana-Farber Cancer Institute offer the best published cure rates for children with acute lymphoblastic leukemia (ALL). These protocols were designed by our own physicians and are used by multiple institutions in the United States and Canada.
We offer comprehensive consultation services to children and families at the time of diagnosis, during therapy, at relapse, and in follow-up. Our services include:
Additional support services we give our patients include:
Our Leukemia Program is committed to recognizing and reducing late effects of treatment in long-term survivors. Our treatment includes innovative approaches designed to reduce these late effects:
Our staff of compassionate and experienced pediatric subspecialists includes oncologists, radiation oncologists, radiologists and pathologists. Our physicians are focused on family-centered care: From your first visit, you'll work with a team of professionals who are committed to supporting all of your family's physical and psychosocial needs.
The Dana-Farber Cancer Institute ALL Consortium, headed by physicians at Dana-Farber Cancer Institute and Boston Children's Hospital, is an international leader in acute lymphoblastic leukemia (ALL) treatment and research. Our achievements include:
Investigational therapies for refractory or relapsed disease, including:
Clinical trials are studies that evaluate the effectiveness of new interventions. There are different types of cancer clinical trials, such as prevention trials, early detection trials, and treatment trials. The Leukemia Program leads many clinical trials and participates in several multi-center national clinical trials.
Referring physicians: 617-632-5508 or 1-888-Pedi-Onc (733-4662)
We know that a leukemia diagnosis is extremely difficult to cope with. We are available to offer a consultation or second opinion for your child.
If your child has a diagnosis of leukemia, please contact our program at 888-PEDI-ONC (1-888-733-4662) or 617-632-5508.
To help us conduct a precise evaluation, it is important we receive a full summary of your child's initial diagnosis. This includes any laboratory or pathology reports, any x-rays, radiographic or MRI images, as well as a list of any previous treatments your child may have received.
Please have as much of the following information as possible when you call or bring it with you to your appointment:
Boston Children's HospitalInpatient Care300 Longwood AvenueBoston, MA 02115
Dana-Farber Cancer InstituteOutpatient Care450 Brookline AvenueBoston, MA 02215
Browse clinical trials
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free:
(866) 408-DFCI (3324)